68 related articles for article (PubMed ID: 22162335)
1. Inhibition of glycoprotein synthesis in the endoplasmic reticulum as a novel anticancer mechanism of (-)-epigallocatechin-3-gallate.
Konta L; Száraz P; Magyar JÉ; Révész K; Bánhegyi G; Mandl J; Csala M
Biofactors; 2011; 37(6):468-76. PubMed ID: 22162335
[TBL] [Abstract][Full Text] [Related]
2. Endoplasmic reticulum stress underlying the pro-apoptotic effect of epigallocatechin gallate in mouse hepatoma cells.
Magyar JE; Gamberucci A; Konta L; Margittai E; Mandl J; Bánhegyi G; Benedetti A; Csala M
Int J Biochem Cell Biol; 2009 Mar; 41(3):694-700. PubMed ID: 18765294
[TBL] [Abstract][Full Text] [Related]
3. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent.
Landis-Piwowar KR; Huo C; Chen D; Milacic V; Shi G; Chan TH; Dou QP
Cancer Res; 2007 May; 67(9):4303-10. PubMed ID: 17483343
[TBL] [Abstract][Full Text] [Related]
4. Carbohydrates act as sorting determinants in ER-associated degradation of tyrosinase.
Svedine S; Wang T; Halaban R; Hebert DN
J Cell Sci; 2004 Jun; 117(Pt 14):2937-49. PubMed ID: 15161941
[TBL] [Abstract][Full Text] [Related]
5. (--)-epigallocatechin gallate enhances prostaglandin F2alpha-induced VEGF synthesis via upregulating SAPK/JNK activation in osteoblasts.
Tokuda H; Takai S; Matsushima-Nishiwaki R; Akamatsu S; Hanai Y; Hosoi T; Harada A; Ohta T; Kozawa O
J Cell Biochem; 2007 Apr; 100(5):1146-53. PubMed ID: 17031857
[TBL] [Abstract][Full Text] [Related]
6. [Epigallocatechin-3-gallate inhibits growth and angiogenesis of gastric cancer and its molecular mechanism].
Zhu BH; Zhan WH; He YL; Cai SR; Wang Z; Zhang CH
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jan; 12(1):82-5. PubMed ID: 19145512
[TBL] [Abstract][Full Text] [Related]
7. (-)-Epigallocatechin gallate inhibits growth and activation of the VEGF/VEGFR axis in human colorectal cancer cells.
Shimizu M; Shirakami Y; Sakai H; Yasuda Y; Kubota M; Adachi S; Tsurumi H; Hara Y; Moriwaki H
Chem Biol Interact; 2010 May; 185(3):247-52. PubMed ID: 20346928
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin gallate dose-dependently induces apoptosis or necrosis in human MCF-7 cells.
Hsuuw YD; Chan WH
Ann N Y Acad Sci; 2007 Jan; 1095():428-40. PubMed ID: 17404055
[TBL] [Abstract][Full Text] [Related]
9. [Impact on tyrosinase expression and export from endoplasmic reticulum by inhibition of 26S proteasome].
Xu W; Lin FQ; Liu JF; Fu LF; Hong WS; Zhou MN; Xu AE; Guan CP
Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(2):123-7. PubMed ID: 23648349
[TBL] [Abstract][Full Text] [Related]
10. EGCG downregulates IL-1RI expression and suppresses IL-1-induced tumorigenic factors in human pancreatic adenocarcinoma cells.
Hoffmann J; Junker H; Schmieder A; Venz S; Brandt R; Multhoff G; Falk W; Radons J
Biochem Pharmacol; 2011 Nov; 82(9):1153-62. PubMed ID: 21787753
[TBL] [Abstract][Full Text] [Related]
11. Green tea polyphenol (-) -epigallocatechin-3-gallate promotes the rapid protein kinase C- and proteasome-mediated degradation of Bad: implications for neuroprotection.
Kalfon L; Youdim MB; Mandel SA
J Neurochem; 2007 Feb; 100(4):992-1002. PubMed ID: 17156130
[TBL] [Abstract][Full Text] [Related]
12. Generation of hydrogen peroxide primarily contributes to the induction of Fe(II)-dependent apoptosis in Jurkat cells by (-)-epigallocatechin gallate.
Nakagawa H; Hasumi K; Woo JT; Nagai K; Wachi M
Carcinogenesis; 2004 Sep; 25(9):1567-74. PubMed ID: 15090467
[TBL] [Abstract][Full Text] [Related]
13. Epigallocatechin-3-gallate inhibits the PDGF-induced VEGF expression in human vascular smooth muscle cells via blocking PDGF receptor and Erk-1/2.
Park JS; Kim MH; Chang HJ; Kim KM; Kim SM; Shin BA; Ahn BW; Jung YD
Int J Oncol; 2006 Nov; 29(5):1247-52. PubMed ID: 17016658
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.
Fassina G; Venè R; Morini M; Minghelli S; Benelli R; Noonan DM; Albini A
Clin Cancer Res; 2004 Jul; 10(14):4865-73. PubMed ID: 15269163
[TBL] [Abstract][Full Text] [Related]
15. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells.
Jung YD; Kim MS; Shin BA; Chay KO; Ahn BW; Liu W; Bucana CD; Gallick GE; Ellis LM
Br J Cancer; 2001 Mar; 84(6):844-50. PubMed ID: 11259102
[TBL] [Abstract][Full Text] [Related]
16. [Effects of green tea extract on expression of human papillomavirus type 16 oncoproteins-induced hypoxia-inducible factor-1alpha and vascular endothelial growth factor in human cervical carcinoma cells].
Tang XD; Zhou X; Zhang QZ; Le AD; Zhou KY
Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(40):2872-7. PubMed ID: 19080502
[TBL] [Abstract][Full Text] [Related]
17. Novel D-ring analog of epigallocatechin-3-gallate inhibits tumor growth and VEGF expression in breast carcinoma cells.
Waleh NS; Chao WR; Bensari A; Zaveri NT
Anticancer Res; 2005; 25(1A):397-402. PubMed ID: 15816564
[TBL] [Abstract][Full Text] [Related]
18. (-)-Epigallocatechin-3-gallate suppresses growth of AZ521 human gastric cancer cells by targeting the DEAD-box RNA helicase p68.
Tanaka T; Ishii T; Mizuno D; Mori T; Yamaji R; Nakamura Y; Kumazawa S; Nakayama T; Akagawa M
Free Radic Biol Med; 2011 May; 50(10):1324-35. PubMed ID: 21277973
[TBL] [Abstract][Full Text] [Related]
19. EGCG inhibits protein synthesis, lipogenesis, and cell cycle progression through activation of AMPK in p53 positive and negative human hepatoma cells.
Huang CH; Tsai SJ; Wang YJ; Pan MH; Kao JY; Way TD
Mol Nutr Food Res; 2009 Sep; 53(9):1156-65. PubMed ID: 19662644
[TBL] [Abstract][Full Text] [Related]
20. Tyrosinase degradation via two pathways during reverse translocation to the cytosol.
Mosse CA; Hsu W; Engelhard VH
Biochem Biophys Res Commun; 2001 Jul; 285(2):313-9. PubMed ID: 11444844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
